Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Grazoprevir is a drug approved for the treatment of hepatitis C. Grazoprevir is a second-generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | Inquiry | Inquiry | |
100 mg | Inquiry | Inquiry |
Description | Grazoprevir is a drug approved for the treatment of hepatitis C. Grazoprevir is a second-generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets. |
Targets&IC50 | GT1a:0.01±0.01 nM (Ki), GT1b:0.01±<0.01 nM (Ki), GT2a:0.08±0.02 nM (Ki), GT2b:0.15±0.06 nM (Ki), GT3a:0.90±0.2 nM (Ki) |
Synonyms | MK 5172 potassium, Grazoprevir, Grazoprevir potassium, MK 5172, MK5172, MK-5172 |
Molecular Weight | 805 |
Formula | C38H49KN6O9S |
CAS No. | 1206524-86-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Grazoprevir potassium salt 1206524-86-8 MK 5172 potassium Grazoprevir Grazoprevir potassium MK 5172 MK5172 MK-5172 inhibitor inhibit